Lv41
480 积分 2021-07-13 加入
BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction
1天前
已完结
The Development of Litifilimab (BIIB 059) for Cutaneous and Systemic Lupus Erythematosus
1天前
已完结
DB-2304, a Duality Immune Modulating Antibody‒Drug Conjugate (DIMAC) targeting BDCA2, displays strong potency in the suppression of pDC functions
4天前
已完结
Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target
5天前
已完结
Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases
5天前
已完结
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
5天前
已完结
AI-driven protein design
9天前
已完结
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia
11天前
已完结
Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia
11天前
已完结
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis
20天前
已完结
皖公网安备34019202002308
